Principal Securities »

Denali Therapeutics shares owned by Principal Securities

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Principal Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $17k 806 21.46

More positions owned by Principal Securities

Ishares Tr Core Us Aggbd Et (AGG)
Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Access Us Agrat (GCOR)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Rus 1000 Etf (IWB)
Principal Exchange Traded Prnc Invt Grad (IG)
Amazon (AMZN)
Apple (AAPL)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Principal Securities

Top funds holding Denali Therapeutics

Baillie Gifford & Co
Vanguard Group
Wellington Management Company
Crestline Management
Baker Bros. Advisors
T. Rowe Price Associates
Flagship Ventures Management
Bank of New York Mellon
Marshall Wace
Credit Suisse
Federated Investors
Casdin Capital
Gilder, Gagnon, Howe & Co
Norges Bank Investment Management
Yiheng Capital

View all funds holding Denali Therapeutics